Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 52.33% vs 65.10% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 102.52% vs 28.70% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 58.82% vs 70.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is -31.81% vs 54.66% in Mar 2025
Compare Balance Sheet Results of Saroja Pharma In
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.02
5.37
-1.35
-25.14%
Share Warrants & Outstandings
Total Reserve
13.27
2.05
11.22
547.32%
Shareholder's Funds
17.29
7.42
9.87
133.02%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
7.36
0.00
7.36
0.00%
Secured Loans
0.03
0.00
0.03
0.00%
Unsecured Loans
7.33
0.00
7.33
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.00
0.00
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.36
-0.00
7.36
0.00%
Current Liabilities
Trade Payables
8.46
1.53
6.93
452.94%
Other Current Liabilities
1.57
2.01
-0.44
-21.89%
Short Term Borrowings
7.05
0.00
7.05
0.00%
Short Term Provisions
0.00
0.03
-0.03
-100.00%
Total Current Liabilities
17.09
3.56
13.53
380.06%
Total Liabilities
41.75
10.99
30.76
279.89%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.90
7.61
-4.71
-61.89%
Less: Accumulated Depreciation
0.72
6.15
-5.43
-88.29%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.18
1.45
0.73
50.34%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
20.34
0.00
20.34
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.54
0.01
0.53
5,300.00%
Long Term Loans & Advances
0.13
1.69
-1.56
-92.31%
Other Non Current Assets
0.00
0.38
-0.38
-100.00%
Total Non-Current Assets
23.19
3.53
19.66
556.94%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.86
2.92
-2.06
-70.55%
Sundry Debtors
17.30
2.09
15.21
727.75%
Cash and Bank
0.34
0.37
-0.03
-8.11%
Other Current Assets
0.03
0.39
-0.36
-92.31%
Short Term Loans and Advances
0.03
1.68
-1.65
-98.21%
Total Current Assets
18.56
7.45
11.11
149.13%
Net Current Assets (Including Current Investments)
1.47
3.89
-2.42
-62.21%
Total Current Assets Excluding Current Investments
18.56
7.45
11.11
149.13%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
41.75
10.99
30.76
279.89%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
14.41
0.00
14.41
0.00%
Book Value per share (adjusted)
43.00
1.38
41.62
3,015.94%
Annual - Borrowings
Borrowings 14.41 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 52.33% vs 65.10% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 22.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 102.52% vs 28.70% in Mar 2025
Annual - Investments
Investments 0.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 58.82% vs 70.00% in Mar 2025
Annual - Current Assets
Current Assets 18.56 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -31.81% vs 54.66% in Mar 2025
Footer loading
